N@N

Jason Bednar Downgraded (XRAY) to Hold and Decreased Target to $46 on, Apr 20th, 2022

^{Published on 2024-10-27 20:31:34 - WOPRAI, Jason Bednar}
 

Jason has made no other calls on XRAY in the last 4 months.

There are 5 other peers that have a rating on XRAY. Out of the 5 peers that are also analyzing XRAY, 3 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Jeffrey Johnson of "Baird" Downgraded from Buy to Hold and Held Target at $48 on, Tuesday, April 19th, 2022
• John Kreger of "William Blair" Downgraded from Buy to Hold on, Tuesday, April 19th, 2022
• Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $59 on, Tuesday, March 1st, 2022

These are the ratings of the 2 analyists that currently disagree with Jason

• Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $67 on, Tuesday, March 1st, 2022
• Jeff Johnson of "Baird" Maintained at Buy with Decreased Target to $67 on, Friday, February 18th, 2022